positive breast cancer gene

Release time ：Nov-15,2024

The presence of breast cancer susceptibility genes indicates that a patient carries specific genetic variations associated with the development of breast cancer. While these variations may elevate an individual's risk of developing the disease, they do not guarantee that the person will inevitably contract it.

In a detailed analysis, breast cancer susceptibility genes can be categorized into several types, ranging from common and low-risk polymorphisms to rare mutations that significantly increase risk. BRCA1 and BRCA2 are two of the most well-known breast cancer susceptibility genes; women with mutations in these genes have a substantially higher lifetime risk of breast cancer compared to the general population. Additionally, there are less common genetic variations such as TP53, PTEN, and CDH1, which are also linked to an increased risk of breast cancer. Detecting these genetic variations can assist in identifying high-risk individuals who might benefit from more intensive surveillance or preventive interventions.

For individuals who test positive for breast cancer susceptibility genes, it is crucial to adhere to medical advice and engage in regular screenings and monitoring. Maintaining a healthy lifestyle, including a balanced diet, regular physical activity, and avoiding smoking, can also contribute to reducing the risk of breast cancer. Under no circumstances should one independently decide to use medication or other treatment methods; such decisions should always be made under the guidance of qualified healthcare professionals.